Modelling within-host immune responses with applications to the Ebola vaccine. 15/07/2023 - 14/07/2024


This PhD project includes the statistical modelling of the results from the EBL2007 clinical trial, which is part of EBOVAC3 (IMI Horizon 2020 project) and aims to investigate the immunogenicity (WP4) of the prophylactic Ebola vaccine in Phase III (developed by Janssen Vaccines & Prevention B.V. in partnership with Bavarian Nordic A/S) in health care providers in the Democratic Republic of Congo (DRC).


Research team(s)

Project type(s)

  • Research Project